GlassScriptPhysician profile
Charlton L Adler
NPI 1275638694
$4,097.64
in general payments reported to CMS, 2019-2025
28 companies · $457 in 2025
The $457 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,194 · 2020: $195 · 2021: $252 · 2022: $1,107 · 2023: $344 · 2024: $548 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,349.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,285.90 | 2021-2025 | |
| Amniox Medical, INC. | $1,091.11 | 2019-2020 | |
| Stryker Corporation | $206.22 | 2024-2025 | Prostep Mica, Hoffmann |
| Organogenesis INC. | $179.65 | 2020-2025 | Puraply Wound Matrix, Apligraf, Via Matrix |
| Treace Medical Concepts, INC. | $168.91 | 2023-2025 | |
| Solventum Corporation | $145.69 | 2024-2025 | V.A.C. Veraflo, 3m Coban, Kerramax Care |
| Celularity INC. | $113.50 | 2020 | |
| Horizon Therapeutics Plc | $105.85 | 2019-2023 | Krystexxa |
| Kerecis Limited | $101.29 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Surgiclose |
| Paragon 28, INC. | $95.25 | 2023 | Total Talus |
| Bioventus LLC | $56.34 | 2020-2025 | Exogen Ultrasound Bone Healing System |
| Kci USA, INC. | $56.19 | 2019-2022 | |
| Djo, LLC | $50.50 | 2023-2025 | Cmf |
| Crossroads Extremity Systems, LLC | $49.15 | 2019 | |
| Paratek Pharmaceuticals, INC. | $46.55 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $40.22 | 2024 | Novosorb Btm |
| Reprise Biomedical, INC. | $38.78 | 2023 | Miro3d |
| Embody, INC. | $34.74 | 2021 | |
| Acera Surgical, INC. | $33.66 | 2022 | |
| Amgen INC. | $31.31 | 2024 | Krystexxa |
| Averitas Pharma INC. | $27.75 | 2024 | Qutenza |
| Access Pro Medical, LLC | $27.09 | 2025 | Matriderm |
| Zimmer Biomet Holdings, INC. | $22.98 | 2019 | |
| Integra Lifesciences Corporation | $22.02 | 2022 | |
| Orthofix Medical, INC. | $20.72 | 2024 | Physio-Stim |
| Depuy Synthes Sales INC. | $16.15 | 2024 | |
| Mimedx Group, INC. | $15.93 | 2024 | |
| Hartmann USA, INC. | $14.19 | 2025 | Zetuvit Plus 10x10 P10 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charlton Adler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.